PHF19 and melanoma: The results determined that compared with that in the corresponding normal groups, PHF19 expression was higher in cancer tissues, such as brain and CNS cancer, breast cancer, colorectal cancer, gastric cancer, head and neck cancer, liver cancer, lung cancer, lymphoma, melanoma, pancreatic cancer, and sarcoma (Figure 1C).